LYTIR

Company · ASND

Ascendis Pharma A/S

Nasdaq's symbol directory lists ASND on Nasdaq as “Ascendis Pharma A/S - Ordinary Share”.

In the 12 months to Nov 19, 2026: insiders bought on 1 occasion ($493K); insiders sold on 3 occasions ($6.2M); 1 planned-sale notice; 3 filings by holders of 5% or more.

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $493K in total; Insider sales: $6.2M in total.Aug: Insider purchases $493KSep: Insider sales $873KNov: Insider sales $5.3MDecJanFebMarAprMayJunJulAugSepOctNov$493K$5.3M
Insider purchases above the line: $493KInsider sales below: $6.2M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG, EVP & Chief Admin Officer sold on 1 day latest Nov 17, 2026 sold $5.3M
  2. Bodenhoff Mads, SVP & PAO sold on 1 day latest Sep 8, 2026 sold $811K
  3. Jean J. Bienaime bought on 1 day latest Aug 14, 2026 bought $493K
  4. HOLTUG LARS sold on 1 day latest Sep 2, 2026 sold $62K
Every trade (4)
  1. SELLPEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG, EVP & Chief Admin Officer sold Nov 17, 2026 20,000 shares filing $5.3M
  2. SELLBodenhoff Mads, SVP & PAO sold Sep 8, 2026 3,000 shares filing $811K
  3. SELLHOLTUG LARS sold Sep 2, 2026 236 shares filing $62K
  4. BUYJean J. Bienaime bought Aug 14, 2026 2,000 shares 2 legs combined filing $493K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG filed Nov 17, 2026 Officer 20,000 shares planned sale date 11/17/2026 filing $5.3M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. T. Rowe Price Investment Management, Inc. filed Nov 16, 2026 Schedule 13G/A passive 8,194,812 shares filing 12.4%
  2. FMR LLC filed Nov 5, 2026 Schedule 13G/A passive 3,425,993 shares filing 5.2%
  3. Artisan Partners Asset Management Inc. filed Aug 13, 2026 Schedule 13G/A passive 2,634,024 shares filing 4.2%

Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.